COVID-19 Vaccine Grants

As a leader in the development of vaccines, Pfizer is proud to support independent efforts in areas of research, education and quality improvement with a primary goal of optimizing the prevention of COVID-19 . Given the urgency and complexity of efforts required to respond to the global pandemic, we are launching our COVID-19 vaccine grant program in phases.

As needs and gaps become clearer, we will be adding goals and areas of interest to the categories below. Please note the following:

  • Currently, we are not accepting applications for clinical research that studies the safety, immunogenicity, and/or efficacy of Pfizer’s COVID-19 vaccine.
  • To ensure vaccine availability for the general public, Pfizer is unable to provide COVID-19 vaccine as part of a grant.

COVID-19 VACCINE GENERAL RESEARCH

Learn more about General Research grants

The following areas of research will be considered:

  • Studies evaluating COVID-19 burden of disease and sero-epidemiological surveys among specific populations.
  • Epidemiology studies evaluating direct & indirect impact, including modeling approaches, of Pfizer’s vaccine particularly in specific patient populations.
  • Studies measuring the impact of efforts to overcome vaccine hesitancy and enhance vaccine uptake.

Submit a new application or view an existing application through our Grant System

COVID-19 VACCINE INDEPENDENT MEDICAL EDUCATION

Coming soon!

Optimize the prevention of COVID-19 by:

  • Increase awareness of the risk of COVID-19 for all ages and racial and ethnic groups.
  • Increase the understanding, and familiarity with, the proper storage, handling and administration of Pfizer’s vaccine.

COVID-19 VACCINE POPULATION HEALTH


Optimize the prevention of COVID-19 by increasing the understanding and familiarity with COVID-19 and Pfizer’s COVID-19 vaccine among the general population.